The Patent Finder

Predicting Likelihood and Site of Metastasis from Patient Records

Tempus AI, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 63/142,051, filed Jan 27, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,145,416Predicting Likelihood and Site of Metastasis from Patient Records
In force
 · High confidence
Tempus AI, Inc.In force
High confidence
US 11,244,763Predicting Likelihood and Site of Metastasis from Patient Records
In force
 · High confidence
Tempus AI, Inc.In force
High confidence
US 11,848,107Predicting Likelihood and Site of Metastasis from Patient Records
In force
 · High confidence
Tempus AI, Inc.In force
High confidence
Application 19/427,895Predicting Likelihood and Site of Metastasis from Patient Records
Pending
Not granted
Tempus AI, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Tempus AI, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited